VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 141 filers reported holding VIKING THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $159 | -31.8% | 14,400 | 0.0% | 0.01% | -27.3% |
Q2 2023 | $233 | -2.9% | 14,400 | 0.0% | 0.01% | -8.3% |
Q1 2023 | $240 | +72.7% | 14,400 | -2.7% | 0.01% | +50.0% |
Q4 2022 | $139 | -99.7% | 14,800 | 0.0% | 0.01% | +300.0% |
Q3 2022 | $40,000 | -7.0% | 14,800 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $43,000 | -2.3% | 14,800 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $44,000 | -35.3% | 14,800 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $68,000 | -34.6% | 14,800 | -10.3% | 0.00% | -40.0% |
Q3 2021 | $104,000 | 0.0% | 16,500 | 0.0% | 0.01% | -16.7% |
Q1 2021 | $104,000 | -2.8% | 16,500 | -13.2% | 0.01% | -33.3% |
Q4 2020 | $107,000 | -14.4% | 19,000 | -11.6% | 0.01% | -25.0% |
Q3 2020 | $125,000 | -8.8% | 21,500 | +13.2% | 0.01% | -7.7% |
Q2 2020 | $137,000 | +53.9% | 19,000 | 0.0% | 0.01% | +18.2% |
Q1 2020 | $89,000 | -42.2% | 19,000 | -1.1% | 0.01% | -21.4% |
Q4 2019 | $154,000 | +16.7% | 19,207 | 0.0% | 0.01% | +7.7% |
Q3 2019 | $132,000 | +36.1% | 19,207 | +64.1% | 0.01% | +30.0% |
Q2 2019 | $97,000 | – | 11,707 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |